ClinicalTrials.Veeva

Menu

Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection (ACTIV4)

E

Eurasian Association of Therapists

Status

Completed

Conditions

Anemia
Chronic Kidney Diseases
Ischemic Stroke
Oncology
Stroke
Diabetes Mellitus
Overweight and Obesity
Myocardial Infarction
Hypertensive Heart Disease
COVID-19
Pulmonary Embolism
Ischemic Heart Disease
Asthma
Atrial Fibrillation
Arrythmia
Chronic Heart Failure
Myocarditis
Copd
DVT

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Depersonalized multi-centered registry initiated to analyze dynamics of non-infectious diseases after SARS-CoV-2 infection in population of Eurasian adult patients.

Full description

Assessment of hospital course and health status during 3, 6, 12 months after discharge in COVID-19 patients in cohorts with comorbidities and without comorbidities. Evaluation of comorbidity impact to severity of novel coronavirus disease and comorbidity impact to demand for medical care.

Enrollment

3,554 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Suspected or confirmed COVID-19

Exclusion criteria

  • Age under 18 years.
  • Refusal to be involved in study;

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems